Opendata, web and dolomites

SIMCARE SIGNED

SImulation-assisted Minimally invasive CAncer tREatment using the gosmart environment

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "SIMCARE" data sheet

The following table provides information about the project.

Coordinator
NUMA ENGINEERING SERVICES LIMITED 

Organization address
address: BLOCK 1 GROUND FLOOR QUAYSIDE BUSINESS PARK MILL STREET
city: DUNDALK LOUTH
postcode: A91
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NUMA ENGINEERING SERVICES LIMITED IE (DUNDALK LOUTH) coordinator 50˙000.00

Map

 Project objective

The objective of this proposal is to assess the potential for commercialisation of an innovative cloud-based software product which will assist interventional radiologists to perform minimally invasive cancer treatments more successfully. There are different approaches to removing tumours in organs (i.e. the liver, kidney and lung) and each has its own advantages and disadvantages, depending on the size and location of the tumour. Minimally invasive cancer treatments offer clear advantages as the procedures are targeted and much less intrusive compared to surgical resection. However, the procedure can be very technical, as the radiologist must understand how the settings of the device affect the heat transfer in the localised region surrounding the tumour. Our software product will bridge this gap and help the radiologist understand how to best perform the treatment within a virtual environment with no risk to the patient. This will bring benefits to the radiological community through more accurate treatments, will make the procedures more efficient and cost-effective, and will reduce the hospital carbon footprint through more integrated collaboration and reduced travel. In addition, as it is web-based, it will help to integrate the global interventional oncology community, providing less experienced clinicians in developing countries with a user-friendly environment to work with their more experienced colleagues on a global basis. During this project, we will enhance our simulation environment and refine our growth projections for the first 8 years on the market. We will also analyse the market needs and define the regulatory requirements for patient data sharing and use of the software in the clinical environment. This information will assist us to understand the most efficient route to bring the software to the market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SIMCARE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SIMCARE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More  

Genetta (2019)

Pole climbing solution to improve safety at work and to prevent fatal accidents in industrial climbing

Read More  

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More